The 7th Applied Bioinformatics and Public Health Microbiology conference provides a multidisciplinary forum to demonstrate how advances in microbial and viral genomics, bioinformatics, data science, and sequencing technology are being used to meet the needs of public health.
Next generation sequencing technologies are producing enormous amount of sequencing data. Analyzing this massive amount of data requires the ability to use the sophisticated tools and techniques in the Unix platform. This course will introduce the participants to the skills needed to get started with their NGS data analysis journey.
The researchers deployed computer programs to pinpoint the pathogenic virus in this mountain of genetic data. Using deep bioinformatic processing, they successfully identified parts of the pathogen's genetic profile and compared them to the profiles of known viruses.
This course aims to provide a hands-on introduction to bioinformatics for next generation sequencing and to equip participants with the essential informatics skills and knowledge required to begin analysing next generation sequencing data and carry out some of the most common types of analysis.
The participants will be provided with end-to-end hands-on training, along with introduction tobasic concepts, in using popular tools and techniques for sequence analysis, structure analysis,function prediction, biological database searching, “omics” data analysis, pathway analysis, datavisualization, data curation and integration, linux, R, perl and scripting basics.rticipants should be comfortable with basic computer skills.
During four plenary sessions, the speakers will focus on the topics:
- Medical Integrative Omics
- Proteomics and Metabolomics
- Structural Bioinformatics
- Systems Biology
A database of bioinformatics and a corresponding data analysis tool.
The Pathogen Portal supports and links to five Bioinformatics Resource Centers (BRCs). Each BRC specializes in a different group of pathogens, focusing on, but not limited to, pathogens causing (Re-Emerging Infectious Diseases, and those in the NIAID Category A-C Priority Pathogen lists for biodefense research.